EFSA says Arla’s protein hydrolysate meets new EU requirement for infant formula, follow-on formula

Article

On February 22, 2022, a new regulation kicked into effect in the EU for infant formulas and follow-on formulas containing protein hydrolysates, requiring companies to submit dossiers on their ingredients so that EFSA can evaluate their safety and suitability for use in these products.

Photo © AdobeStock.com/279photo

Photo © AdobeStock.com/279photo

The European Food Safety Authority (EFSA) published a positive opinion acknowledging that Arla Foods Ingredients’ Peptigen IF-3080 protein hydrolysate ingredient is safe for use in infant formulas and follow-on formulas in the EU.

On February 22, 2022, a new regulation kicked into effect in the EU for infant formulas and follow-on formulas containing protein hydrolysates, requiring companies to submit dossiers on their ingredients so that EFSA can evaluate their safety and suitability for use in these products. Ingredients not approved cannot be sold in the market in these products.

Arla Foods Ingredients’ Peptigen IF-3080 is “one of only a few milk protein hydrolysate ingredients to receive a positive EFSA opinion to date,” the company stated in a March 2022 press release.

“We are delighted by this opinion, which supports our reputation for having the industry’s highest levels of quality, innovation, and food safety,” stated Anders Steen Jørgensen, head of SBU Pediatric, Arla Foods Ingredients, in the press release.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.